Concepedia

Kamil Szeliski

KS

Statistics

Publications

6

Citations

180

H-Index

6

Active since

2020

Affiliations

Nicolaus Copernicus University(Current)

Kamil Szeliski is an author at Nicolaus Copernicus University specializing in oncology, cytotoxic chemotherapy, and pharmacology.

ORCID

Publications per year

2020–2023

6

Publications

6

A comprehensive evaluation of flexible FDM/FFF 3D printing filament as a potential material in medical application

Agnieszka Haryńska, Paulina Kosmela, Kamil Szeliski et al. · European Polymer Journal · 2020 · 74 citations

, , +12

Ciprofloxacin and Levofloxacin as Potential Drugs in Genitourinary Cancer Treatment—The Effect of Dose–Response on 2D and 3D Cell Cultures

Tomasz Kloskowski, Kamil Szeliski, Zuzanna Fekner et al. · International Journal of Molecular Sciences · 2021 · 39 citations · Full text

, , +15

Mumio (Shilajit) as a potential chemotherapeutic for the urinary bladder cancer treatment

Tomasz Kloskowski, Kamil Szeliski, K. Krzeszowiak et al. · Scientific Reports · 2021 · 30 citations · Full text

, , +11

Molecular Aspects of Adipose-Derived Stromal Cell Senescence in a Long-Term Culture: A Potential Role of Inflammatory Pathways

Marta Pokrywczyńska, Małgorzata Maj, Tomasz Kloskowski et al. · Cell Transplantation · 2020 · 14 citations · Full text

, , +16

CD133 Antigen as a Potential Marker of Melanoma Stem Cells: In Vitro and In Vivo Studies

Tomasz Kloskowski, Joanna Jarząbkowska, Arkadiusz Jundziłł et al. · Stem Cells International · 2020 · 12 citations · Full text

, , +15

1–5 of 6